Ophthalmic Formulations: Equivalence and Patient Care

CHICAGO FACULTY
L. Jay Katz, MD Director of the Glaucoma Service at Wills Eye Institute Professor at Jefferson Medical College Steven T. Simmons, MD Glaucoma Consultants Slingerlands, NY	Robert D. Fechtner, MD Director of the Glaucoma Division at UMDNJ Professor of Ophthalmology at the Institute of Ophthalmology New Jersey Medical School, Newark Richard G. Fiscella, PharmD, MPH Clinical Professor Department of Pharmacy Practice University of Illinois at Chicago
NASHVILLE FACULTY Steven T. Simmons, MD Glaucoma Consultants Slingerlands, NY

Learning Objectives

Upon the completion of this activity, the participant should be able to:

Understand the pros and cons of generic medications versus brand-name formulations
Recognize the importance of patients' adherence to prescribed glaucoma therapy in medical outcomes
Identify the key barriers to patients' adherence to prescribed glaucoma medical therapy
Employ effective strategies to ensure that patients receive the medications prescribed and facilitate their appropriate long-term use

Designation Statement
The Dulaney Foundation designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dulaney Foundation, Glaucoma Today, and Advanced Ocular Care. The Dulaney Foundation is accredited by the ACCME to provide continuing medical education for physicians.